Association of HLA-Class II with prognosis and clinical features in sarcoidosis

T. Tachibana, M. Sakatani, Y. Fukumori, Y. Tani (Osaka, Sakai, Japan)

Source: Annual Congress 2006 - Sarcoidosis
Session: Sarcoidosis
Session type: Poster Discussion
Number: 2108

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Tachibana, M. Sakatani, Y. Fukumori, Y. Tani (Osaka, Sakai, Japan). Association of HLA-Class II with prognosis and clinical features in sarcoidosis. Eur Respir J 2006; 28: Suppl. 50, 2108

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

HLA-class I and II genotyping in sarcoidosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 354s
Year: 2006

Prognostic value of HLA typing in Irish patients with pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 107s
Year: 2001

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Association of demographic, laboratory and clinical parameters with HRCT-chest findings in patients with sarcoidosis.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

Clinical and functional staging of COPD
Source: Annual Congress 2004 - Diagnosis and staging of COPD
Year: 2004

Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


HLA antigens in Turkish patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Management of sarcoidosis in clinical practice
Source: Eur Respir Rev 2016; 25: 141-150
Year: 2016



Analysis of HLA antigens in Turkish sarcoidosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 257s
Year: 2003

Association between age and clinical characteristics and outcomes of COVID-19
Source: Eur Respir J, 55 (5) 2001112; 10.1183/13993003.01112-2020
Year: 2020



Severe sarcoidosis: clinical features and management
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Clinical spectrum and outcome of non IPF patients with a typical UIP picture
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Association study of ANXA11-R230C with sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012

Thymoma: Clinical features and prognostic factors in 47 patients
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013